TY - JOUR T1 - Effectiveness of Emotion Regulation Training on Perceived Stress, Self-Efficacy and Sleep Quality in the Elderly With Type 2 Diabetes (T2D) TT - اثربخشی آموزش تنظیم هیجان بر استرس ادراک‌شده، خودکارآمدی و کیفیت خواب سالمندان مبتلا به دیابت نوع 2 JF - hums-jpm JO - hums-jpm VL - 9 IS - 2 UR - http://jpm.hums.ac.ir/article-1-627-en.html Y1 - 2022 SP - 132 EP - 143 KW - Emotional focused therapy KW - Stress KW - Self-efficacy KW - Sleep quality KW - Elderly N2 - Objective The aim of this study was to evaluate the effectiveness of emotion regulation skills training to reduce perceived stress and increase self-efficacy and improve sleep quality in the elderly with type 2 diabetes. Methods The present study was an applied study and its method was quasi-experimental with a pretest-posttest design with a control group. The study population was all elderly people aged 65 years and older with type 2 diabetes living in Kish Island in the year 1400. Thirty of them were selected as a sample group by purposive sampling and then were randomly divided into experimental and control groups. Then, the experimental group was exposed to 8 sessions of emotion regulation training and in three stages of pre-test-post-test and follow-up through Cohen et al. (2004) Perceived Stress Scale. Scherer et al. (1982) self-efficacy questionnaire and Pittsburgh (1989) sleep quality questionnaire were evaluated. Data analysis was performed by repeated measures analysis using SPSS software v. 26. Results results showed that the interactive effect of time×group on perceived stress (P=0.001, F=42.02), on self-efficacy (P=0.001, F=81.845) And on the quality of sleep of the elderly (P=0.001, F=5.410) is significant at a significant level (P<0.01) and the effect of intervention leads to a reduction in stress, and increase self-efficacy and sleep quality in experimental group. Conclusion Based on the findings of this study, emotion regulation training can be used to reduce perceived stress and improve self-efficacy and sleep quality in the elderly with type 2 diabetes. M3 10.32598/JPM.9.2.2 ER -